# Entrada Therapeutics, Inc.: Form 8-K, filed Apr 29, 2025

- Company: [Entrada Therapeutics, Inc.](/companies/trda.md) (CIK 1689375)
- Form: 8-K
- Filed: 2025-04-29
- Accepted by EDGAR: Apr 29, 2025, 16:05 ET
- Period: 2025-04-29
- Accession: 0001104659-25-041204
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1689375/000110465925041204/tm2513421d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1689375/000110465925041204/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1689375/000110465925041204/tm2513421d1_8k.htm

Filed Apr 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-041204. Last ingested by Listed: Nov 5, 2026, 11:57 ET. No prices; not investment advice.